Text Size

Using Diagnostic Tools to Stage Breast Cancer

The recruitment status of this study is unknown because the information has not been verified recently.
Verified May 2007 by University of Pennsylvania.
Recruitment status was  Active, not recruiting
Sponsor:
Information provided by:
University of Pennsylvania
ClinicalTrials.gov Identifier:
NCT00367666
First received: August 22, 2006
Last updated: May 8, 2007
Last verified: May 2007
History of Changes
  Purpose

This project is aimed at investigating the relative diagnostic and synergy of four state of the art breast imaging techniques (magnetic resonance imaging (MRI), full-field digital mammography (DMAM), ultrasound, and positron emission tomography (PET)) with respect to determining the extent of breast cancer.


Condition Intervention
Breast Cancer
 Device: MRI, Digital Mammography, Ultrasound and Positron Emission Tomography (PET)

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Diagnostic
Official Title: Evaluation of Multimodality Breast Imaging: Lesion Staging

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by University of Pennsylvania:

Estimated Enrollment: 400
Study Start Date: March 2002
Estimated Study Completion Date: July 2007
  Eligibility

Ages Eligible for Study:   18 Years to 80 Years
Genders Eligible for Study:   Female
Criteria

Inclusion Criteria:

  • Women recently diagnosed with Breast Cancer
  • Will be undergoing surgery (after study) at the Hospital of the University of Pennsylvania

Exclusion Criteria:

  • Contraindications to MRI
  • previously diagnosed with breast cancer (in the smae breast) within the past 5 years
  • Patients with known locally advanced cancer (prior to study entry) being treated with preoperative adjuvant therapy.
  • Pregnant women
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00367666

Locations
United States, Pennsylvania
University of Pennsylvania
Philadelphia, Pennsylvania, United States, 19104
Sponsors and Collaborators
University of Pennsylvania
Investigators
Principal Investigator: Abass Alavi, MD University of Pennsylvania
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00367666     History of Changes
Other Study ID Numbers: Protocol 414500, NIH funded
Study First Received: August 22, 2006
Last Updated: May 8, 2007
Health Authority: United States: Institutional Review Board

Additional relevant MeSH terms:
Breast Neoplasms
Neoplasms by Site
Neoplasms
Breast Diseases
Skin Diseases

ClinicalTrials.gov processed this record on May 23, 2013